组装的固定剂量组合药片治疗高血压:灵感来自乐高建筑的模块化设计
Tanikan Sangnim1, Kittipat Suwanpitak1, Pornsak Sriamornsak2
1Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, 20131, Thailand.
概括
这项研究介绍了一种新的,以乐高®为灵感的系统,用于制造可定制的固定剂量组合 (FDC) 高血压药片. 模块化设计允许个性化剂量,但药物释放严重取决于每个活性药物成分所选择的聚合物矩阵.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 材料科学 材料科学 材料科学
背景情况:
- 治疗高血压等慢性疾病的多药性药物对坚持和有效性提出了挑战.
- 传统的固定剂量组合 (FDC) 片提供了更好的坚持,但缺乏个性化的剂量灵活性.
研究的目的:
- 开发和描述一种新的,灵感来自乐高的组装FDC平板电脑系统,用于可定制的抗高血压治疗.
- 在FDC系统中评估不同聚合物矩阵对于单个药物模块的适用性.
主要方法:
- 使用3D打印模具创建可堆叠的单个药物模块 (阿姆洛迪平,瓦尔萨坦,甲).
- 研究了两种聚合物矩阵 (基于凝和基于HPMC) 的药物配方和释放特征.
- 根据USP溶解标准评估药物释放配置文件.
主要成果:
- 凝矩阵促进了阿姆洛迪平和瓦尔萨坦的快速释放,符合USP标准.
- HPMC矩阵能够控制释放甲 (HCTZ),但不适合安洛迪平和瓦尔萨坦.
- 证明了API特定的聚合物矩阵要求,以实现所需的溶解配置.
结论:
- 验证了个性化多药房模块化FDC系统的概念验证.
- 突出了针对API的聚合物选择的关键需求,以克服模块化FDC系统中的配方挑战.
- 开发的系统显示了针对量身定制的抗高血压治疗的前景.
相关概念视频
Brick Sizes
291
Brick sizing plays a crucial role in construction, influencing both the aesthetics and structural integrity of buildings. Bricks are defined by three dimensions: width, thickness, and length. They are commonly designed to fit modular measurements, typically in multiples of 4 inches or 8 inches in width, to facilitate uniform construction and compatibility with other building materials.
Modular bricks are the most common type and are sized to include the mortar joint, which is essential for...
Modular bricks are the most common type and are sized to include the mortar joint, which is essential for...
291
Antihypertensive Drugs: Types of β-Blockers
1.4K
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
1.4K
Hypertension IV: Drug Therapy and Lifestyle Modifications
610
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
610
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Antihypertensive Drugs: Action of β1 Blockers
1.9K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.9K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K


